Author: Andrew Brantingham

Andrew's experience spans a wide range of industries, and has particular depth in the health care field (including medical malpractice defense, government investigations, False Claims Act matters, and commercial litigation involving health systems, medical device firms, and others), federal Indian law (representing tribes across the nation as well as nontribal firms doing business in Indian Country), and the financial services industry (including class actions, broker-dealer disputes, and securities litigation).

Coronavirus Lawsuits More Than Double In 2021; Those Against Healthcare Providers Steadily Increase

Despite widespread vaccine availability and the corresponding optimism about returning to “normal,” the coronavirus pandemic continues to spawn hundreds of employment and health-related lawsuits.  Many of these lawsuits have been aimed at employers in the healthcare sector and relate to workplace safety, retaliation, and wrongful termination or wrongful denial of leave.  In fact, since our...

False Claims Act Exposure for Beneficiaries of the Public Health and Social Services Emergency Relief Fund: Mitigating Risks of Ambiguous Terms & Conditions

The Dorsey Health Law blog team keeps readers up-to-date on relevant topics in the health care industry. In order to do so, the members of the blog team communicate regularly with other practice groups within the firm for applicable updates from client publications. For this post, we would like to thank Andrew Brantingham, Ross C....

Untimely Dispensing Allegations Against Pharmacies Stricken in Opioid Litigation

As the world grapples with the health crisis caused by COVID-19, litigation regarding a different health crisis—the opioid epidemic—continues to progress (see our previous posts on this topic here and here). In a major development last week for the multidistrict litigation, the Sixth Circuit concluded that key bellwether cases against twelve large pharmacy chains may...

Drug Companies Preview Trial Defenses for Bellwether Opioid Trial

In the last several years, thousands of cities and counties, as well as most states, have sued various combinations of pharmaceutical manufacturers, retailers, and distributors for damages allegedly caused by the opioid epidemic.  Nearly 2,000 of those cases have been consolidated into a multi-district litigation (“MDL”) in the Northern District of Ohio. Until very recently,...